Viyash Scientific Ltd reports Q2 FY27 revenue of ₹987.9 crore, up 16.2% year on year
- EBITDA before ESOP cost was ₹207.7 crore, up 10.3% year on year; margin was 21.0%, down 110 bps.
- Net profit rose 16.1% year on year to ₹84.7 crore; ESOP expense was ₹42.1 crore and exceptional items were nil.
- Completed the BioForLife acquisition in Italy and outlined investments in oncology R&D, companion-animal manufacturing and API capacity.
